Fluomizin Uses, Dosage, Side Effects and more

Fluomizin (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrx’s patented ReCODE™ technology to achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth hormone, by biosynthetic incorporation of a chemically unique amino acid (ahGH). Fluomizin has improved pharmacological properties, which should allow less frequent administration than the daily dosing regimen of currently available growth hormones.

Attribute	Details
Trade Name	Fluomizin
Generic	ARX201
Type
Groups	Investigational
Therapeutic Class
Manufacturer	Kora Healthcare
Available Country	United Kingdom, Portugal, Switzerland
Last Updated:	January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in growth hormone deficiencies/abnormalities.

Innovators Monograph